Elkins-Sinn's pancuronium bromide
Executive Summary
ANDA approval for generic version of Organon's injectable Pavulon muscle relaxant granted March 23. Elkins-Sinn estimates size of market at $ 21 mil. and anticipates launch of the injectable product in approximately 30 days.